#21
RANDOMIZED CONTROLLED TRIAL
Joseph P McEvoy, Matthew Byerly, Robert M Hamer, Rosalie Dominik, Marvin S Swartz, Robert A Rosenheck, Neepa Ray, J Steven Lamberti, Peter F Buckley, Tania M Wilkins, T Scott Stroup
IMPORTANCE: Long-acting injectable antipsychotics are used to reduce medication nonadherence and relapse in schizophrenia-spectrum disorders. The relative effectiveness of long-acting injectable versions of second-generation and older antipsychotics has not been assessed. OBJECTIVE: To compare the effectiveness of the second-generation long-acting injectable antipsychotic paliperidone palmitate with the older long-acting injectable antipsychotic haloperidol decanoate...
May 21, 2014: JAMA
1